Please take our CLL Society's CAR-T Survey! At ASH 2020 we learned that CAR-T cells may soon have an important place in treating CLL. Patients currently receiving CAR-T cells in clinical trials are experiencing fewer toxicities and many are having durable responses. As CLL Society continues to plan educational programs around these important developments, please help us by sharing what you currently know about CAR-T therapy. Take our CAR-T survey here. Thank you! cllsociety.org/2020/12/ask-...
Please help CLL Society learn more about what ... - CLL Support
Please help CLL Society learn more about what you know and/ or yearn to know more about CAR-T therapy.
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
As always, thank you for doing this Dr. Koffman, it really helps
Not what you're looking for?
You may also like...
Tuesday! Nov. 17th CLL Society Webinar "The Future of CAR-T Therapy: Can CAR-T Cure CLL?”
Tuesday! Nov. 17th CLL Society Webinar "The Future of CAR-T Therapy: Can CAR-T Cure CLL?” Claim...
The current status and challenges of CAR-T therapy in CLL
A few members of this group are scheduled for CAR-T and others might find themselves in the same...
More CAR-T: Looking Back to Go Forward in CAR-T Cell Therapy in R/R CLL
Long-term data from a phase 1 study investigating anti-CD19 chimeric antigen receptor (CAR) T-cell...
CD3xCD19 Dart Treatment Is Efficient in Venetoclax Resistant CLL and Reverses T Cell Dysfunction
DART (rather than CART) treatment could be come important in the future, especially for CLL where...
Dr. Neil Kay: CLL Society Webinar, Just Diagnosed: What Do I Need to Know?
HI,
Please join us for a CLL Society Webinar, Just Diagnosed: What Do I Need to Know? on Tuesday,...
Is It Time to Treat Your CLL? What You Need to Know
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
Heard a distant ROR; now getting a bit closer?
The health of our T cells…
